Exosome miR‐6990‐5p from MMP14 high Macrophage Promotes Fibrosis Through Th17 Cell Differentiation in Hypersensitivity Pneumonia
European Journal of Immunology · 2025
DOI: 10.1002/eji.70048 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Journal of Immunology, 2025. Verfasst von Dan Peng und 10 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Allergy and Precision Medicine, Chengdu Institute of Respiratory Health, the Third People's Hospital of Chengdu, the Affiliated Hospita…. Hauptthemen laut MEDLINE: MicroRNAs, Th17 Cells, Macrophages, Pulmonary Fibrosis. Die Arbeit nennt 41 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Sichuan Province, Health Commission of Chengdu Medical Research Program.
Abstract (Originalsprache)
Th17 cells contribute to pulmonary fibrosis, but the mechanisms driving their differentiation remain unclear. Using single‐cell RNA sequencing (scRNA‐seq) and a decision tree model, we identify IL17A as a key marker in mice exposed to Saccharopolyspora rectivirgula antigen (SR‐Ag). Trajectory and T cell receptor (TCR) analyses reveal IL17A⁺ CD4 T cells as terminally differentiated and clonally expanded. Blocking IL17A reduces SR‐Ag–induced lung inflammation and fibrosis. Exosomal miR‐6990‐5p from MMP14‐overexpressing macrophages promotes Th17 differentiation and fibroblast‐to‐myofibroblast transition (FMT) in vitro. It directly targets STAT1, as confirmed by luciferase assays. Co‐immunoprecipitation (Co‐IP) and docking analyses show STAT1 interacts with ROR‐γt and RUNX1. STAT1 knockdown upregulates ROR‐γt, IL17A, and RUNX1 in co‐cultures with naïve CD4 T cells. In vivo, miR‐6990‐5p exacerbates fibrotic hypersensitivity pneumonitis (FHP) in SR‐Ag‐exposed mice. These findings indicate that miR‐6990‐5p induces Th17 cell differentiation through the STAT1/RUNX1/ROR‐γt/IL17A pathway, contributing to FMT and fibrosis progression. This highlights miR‐6990‐5p as a potential therapeutic target for FHP.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Laboratory of Allergy and Precision Medicine, Chengdu Institute of Respiratory Health, the Third People's Hospital of Chengdu, the Affiliated Hospital of Southwest Jiaotong University, Chengdu, Sichuan, China.
- Laboratory of Allergy and Precision Medicine, Chengdu Institute of Respiratory Health, the Third People's Hospital of Chengdu, the Affiliated Hospital of Southwest Jiaotong University, College of Medicine, Southwest Jia…
ORCID-Profile: Guoping Li
Förderung
- National Natural Science Foundation of China
- Natural Science Foundation of Sichuan Province
- Health Commission of Chengdu Medical Research Program
- Chengdu High-level Key Clinical Specialty Construction Project
- The Third People's Hospital of Chengdu Clinical Research Program
Zitieren
APA
Peng, D., Li, J., Qin, B., Xiong, A., Ran, Q., Bai, L., He, X., Li, X., Zhang, L., Arooj, M., & Li, G. (2025). Exosome miR‐6990‐5p from MMP14 high Macrophage Promotes Fibrosis Through Th17 Cell Differentiation in Hypersensitivity Pneumonia. European Journal of Immunology. https://doi.org/10.1002/eji.70048
Vancouver
Peng D, Li J, Qin B, Xiong A, Ran Q, Bai L, et al. Exosome miR‐6990‐5p from MMP14 high Macrophage Promotes Fibrosis Through Th17 Cell Differentiation in Hypersensitivity Pneumonia. European Journal of Immunology. 2025. doi:10.1002/eji.70048
BibTeX
@article{Peng2025,
author = {Peng, Dan and Li, Juan and Qin, Bomiao and Xiong, Anying and Ran, Qin and Bai, Lingling and He, Xiang and Li, Xiaolan and Zhang, Lei and Arooj, Madeeha and Li, Guoping},
title = {Exosome miR‐6990‐5p from MMP14 high Macrophage Promotes Fibrosis Through Th17 Cell Differentiation in Hypersensitivity Pneumonia},
journal = {European Journal of Immunology},
year = {2025},
doi = {10.1002/eji.70048}
}
EUVIMED